- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Eli Lilly and Co.
Lilly to sell Lafayette plant to German firm
October 14, 2009
J.K. WallNearly 700 workers will be offered severance, new jobs
MoreBaucus health reform bill would stick Indiana companies with fees
October 10, 2009
IBJ StaffThe health reform bill sponsored by U.S. Sen. Max Baucus, D-Mont., would help pay for expanded health insurance coverage
by levying fees of $13 billion a year on the health care industry. The fees would deliver a hefty bill to just
about all of Indiana’s major health care companies. But how they’re reacting to the fees is all over the map.
MoreLilly settles Zyprexa suit with S. Carolina
October 7, 2009
IBJ StaffEli Lilly and Co. has agreed to settle the State of South Carolina's lawsuit that claimed Lilly improperly marketed the antipsychotic
drug Zyprexa, according to Bloomberg News.
MoreLilly's win in Evista patent case crucial, analyst says
September 24, 2009
Scott OlsonA decision by a federal judge in Indianapolis to turn back a patent challenge to Eli Lilly and Co.'s Evista marks a major
victory for the company, says an analyst who closely follows the pharmaceutical industry.
MoreJudge upholds Lilly's Evista patent
September 24, 2009
J.K. WallA federal judge in Indianapolis turned back a patent challenge to Eli Lilly and Co.’s drug Evista, the company announced
late yesterday.
MoreLilly agrees to settle more state Zyprexa suits
September 22, 2009
Eli Lilly and Co. has agreed to confidential terms to settle lawsuits brought by seven states alleging the company illegally
marketed bestselling antipsychotic drug Zyprexa, Bloomberg News reported today.
MoreLilly revises playbook in effort to score more 'touchdowns'
September 19, 2009
J.K. WallThe drugmaker has successfully moved experimental drugs into position to win approval by regulators. But only once in the
last four years has a new drug actually made it to market—the industry’s equivalent of getting
across the goal line.
MoreUPDATE: Pipeline challenges force Lilly restructuring moves
September 14, 2009
J.K. WallSince John Lechleiter was named CEO 18 months ago, he's bet that Eli Lilly and Co. could face down its looming patent challenges
by launching innovative new medicines. Today's announcement of 5,500 job cuts by the end of 2011 and a restructuring of the
company's business units ups the ante on that bet, while indicating that it isn't working yet.
MoreLilly reorganization to cut 5,500 positions over 2 years
September 14, 2009
J.K. WallEli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.
MoreLocal health care industry tries to capitalize on migraine headaches
September 12, 2009
J.K. WallMigraines cost American employers $20 billion a year in decreased worker productivity. Such
a frequent and uncured disease stands as a huge business opportunity for the health care industry, including locally based
pharmaceutical giant Eli Lilly and Co.
MoreStudy weakens Lilly's fight against price controls
September 12, 2009
IBJ StaffEli Lilly and Co. and its peers might be back in Congress’ sights as lawmakers hunt for more ways to cut health care
costs. A new study in the influential Health Affairs journal concludes that European drugmakers operating
in markets with pharmaceutical price controls have produced proportionally more innovations than their U.S. counterparts.
MoreLilly paid doctors to prescribe Zyprexa, notes say
September 8, 2009
IBJ StaffEli Lilly and Co. paid doctors in South Carolina for participating in a speakers' program in exchange for prescribing the
antipsychotic Zyprexa, according to notes by Lilly sales representatives reviewed by Bloomberg News.
MoreLilly drops osteoporosis pipeline drug
August 18, 2009
J.K. WallEli Lilly and Co. pulled the plug on yet another drug in its pipeline that was in the late stages of testing, further complicating
the company’s attempts to find revenue before losing patent protection on its bestseller.
MoreLilly pays $224,000 to area doctors
August 17, 2009
IBJ StaffIt’s no secret that Eli Lilly and Co. is the biggest private employer in the Indianapolis area. But
Lilly also supplemented the incomes of a few dozen local doctors — to the tune of more than $224,000 in just the first
quarter.
MoreGlut of downtown office space grows
August 17, 2009
Cory SchoutenSafeco is leaving a five-building complex on North Meridian Street, and Eli Lilly and Co. has offered for lease its entire
four-building Faris campus.
MoreAbatement approval paves way for Covance jobs
August 12, 2009
Scott OlsonThe Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
MoreLilly reorganizes venture capital unit
August 10, 2009
Peter SchnitzlerEli Lilly and Co. has reorganized its venture capital division and simultaneously poured in an additional $25 million.More
Lilly offering buyouts to 4,000 sales reps
August 4, 2009
Indianapolis-based Eli Lilly and Co. today said it is offering buyouts to its U.S. sales force,
with hopes of trimming about 300 sales representatives before a sales restructuring set to begin in January, Reuters reported.
MoreLilly software spinoff Maaguzi sells for $11 million
August 3, 2009
Chris O'MalleyInvestors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
MoreLilly's Effient launch just one of its many challenges
August 3, 2009
Greg AndrewsEli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials
take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.
MoreEli Lilly CEO, wife give United Way $1M gift
July 28, 2009
Kathleen McLaughlinEli Lilly and Co. CEO John Lechleiter and his wife, Sarah, have pledged to give the United Way of Central Indiana a total
of $1 million over the next four years as a “challenge to CEOs and other community leaders to step up their giving.”
MoreEli Lilly CEO, wife give United Way $1M gift
July 28, 2009
Kathleen McLaughlinEli Lilly and Co. CEO John Lechleiter and his wife, Sarah, have pledged to give the United Way
of Central Indiana a total of $1 million over the next four years as a "challenge to CEOs and other community leaders to step
up their giving."
MoreLilly cancels trials for experimental MS drug
July 28, 2009
J.K. WallEli Lilly and Co. and a development partner has canceled clinical trials on an experimental drug to treat multiple sclerosis
after the drug failed to delay progression of the disease in trial patients.
MoreBREAKING: FDA approves Lilly blood-thinner prasugrel
July 10, 2009
J.K. WallEli Lilly and Co. finally won approval today from U.S. regulators to sell prasugrel, its highly anticipated blood thinner,
according to Bloomberg News.
MoreLilly cancer drug OK'd for new use
July 6, 2009
J.K. WallEli Lilly and Co.'s top rising-star drug has been approved by U.S. regulators for a new use, an event that could boost sales
of
the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer
for certain patients, Lilly announced today.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Ameriana Bank took over Westfield Farmers Market for 2013 and it is held in their parking lot, corner of 32 and Carey road, 5 to 8. I am selling soap and candles there. great market!
B&T certainly has enough of our taxpayer dollars to do this thanks to Mayor Ballard. Given the firm's exceedingly poor reputation in the legal community, the basement would seem a better option.
Should read MAY hire 20 people.
Not a good location for a 300,000 home. 10th Street fumes, buses, noise. Max for this location 150,000.
The state constitution also does not say that the majority has a right to quorum, nor that the minority is required to allow them quorum. In fact, denial of quorum has been a parliamentary maneuver since the establishment of the first parliaments in the early 1600s. The right to deny quorum (and the requirement fore quorum) are to prevent exactly what happened in Indiana: A tyrannical majority pushing through odious, objectionable legislation. Denial of quorum is totally legitimate, and lest we forget, a tactic the GOP has employed many, many times to ensure their issues weren't given short shrift. By allowing the majority to impose "fines" on the minority for exercising the authority the constitution grants them (to deny quorum,) they are violating the constitution.